TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1896531
log Bayes Factor = 6.41582
Chromosome 10   position 126,581,891  (GRCh37) Explore rs1896531 on Ensembl!
Variant rs1896531 is part of Cluster X0278

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Chapter XIII Diseases of the musculoskeletal system and connective tissue
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
1.000 0.000 0.000
M50-M54 Other dorsopathies
1.000 0.000 0.000
Chapter XX External causes of morbidity and mortality
1.000 0.000 0.000
M51 Other intervertebral disk disorders
0.999 0.001 0.000
M51.2 Other specified intervertebral disk displacement
0.998 0.002 0.000
M45-M49 Spondylopathies
0.997 0.003 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.995 0.005 0.000
E70-E90 Metabolic disorders
0.988 0.012 0.000
Y43 Primarily systemic agents
0.987 0.013 0.000
E83 Disorders of mineral metabolism
0.983 0.017 0.000
E10-E14 Diabetes mellitus
0.982 0.018 0.000
M20-M25 Other joint disorders
0.982 0.018 0.000
Chapter V Mental and behavioural disorders
0.977 0.023 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.973 0.027 0.000
Y43.3 Other antineoplastic drugs
0.969 0.031 0.000
M47 Spondylosis
0.968 0.032 0.000
M48 Other spondylopathies
0.967 0.033 0.000
E20-E35 Disorders of other endocrine glands
0.965 0.035 0.000
E10 Insulin-dependent diabetes mellitus
0.964 0.036 0.000
M48.0 Spinal stenosis
0.952 0.048 0.000
Y95 Nosocomial condition
0.945 0.055 0.000
E83.4 Disorders of magnesium metabolism
0.943 0.057 0.000
E10.9 Without complications
0.941 0.059 0.000
X60-X84 Intentional self-harm
0.940 0.060 0.000
M54 Dorsalgia
0.936 0.064 0.000
Chapter XIV Diseases of the genitourinary system
0.930 0.070 0.000
M47.9 Spondylosis, unspecified
0.928 0.072 0.000
N10-N16 Renal tubulo-interstitial diseases
0.923 0.077 0.000
F30-F39 Mood [affective] disorders
0.919 0.081 0.000
N13 Obstructive and reflux uropathy
0.914 0.086 0.000
M48.07 Spinal stenosis (Lumbosacral region)
0.907 0.093 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.905 0.095 0.000
Y40 Systemic antibiotics
0.903 0.097 0.000
Chapter VI Diseases of the nervous system
0.896 0.104 0.000
E83.5 Disorders of calcium metabolism
0.895 0.105 0.000
M23 Internal derangement of knee
0.895 0.105 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.893 0.107 0.000
E83.1 Disorders of iron metabolism
0.887 0.113 0.000
G90-G99 Other disorders of the nervous system
0.887 0.113 0.000
M86-M90 Other osteopathies
0.886 0.114 0.000
E11 Non-insulin-dependent diabetes mellitus
0.884 0.116 0.000
W20-W49 Exposure to inanimate mechanical forces
0.883 0.117 0.000
M35 Other systemic involvement of connective tissue
0.879 0.121 0.000
F32 Depressive episode
0.875 0.125 0.000
E28 Ovarian dysfunction
0.875 0.125 0.000
M51.8 Other specified intervertebral disk disorders
0.870 0.130 0.000
X62.9 Unspecified place
0.859 0.141 0.000
F32.9 Depressive episode, unspecified
0.854 0.146 0.000
M48.06 Spinal stenosis (Lumbar region)
0.852 0.148 0.000
Chapter VII Diseases of the eye and adnexa
0.851 0.149 0.000
E11.9 Without complications
0.850 0.150 0.000
E50-E64 Other nutritional deficiencies
0.850 0.150 0.000
M47.96 Spondylosis, unspecified (Lumbar region)
0.849 0.151 0.000
M21 Other acquired deformities of limbs
0.848 0.152 0.000
M51.0 Lumbar and other intervertebral disk disorders with myelopathy
0.845 0.155 0.000
M23.8 Other internal derangements of knee
0.843 0.157 0.000
M54.2 Cervicalgia
0.842 0.158 0.000
M25 Other joint disorders, not elsewhere classified
0.841 0.159 0.000
G95 Other diseases of spinal cord
0.840 0.160 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.837 0.163 0.000
M23.3 Other meniscus derangements
0.835 0.165 0.000
N13.6 Pyonephrosis
0.834 0.166 0.000
N17-N19 Renal failure
0.831 0.169 0.000
N60-N64 Disorders of breast
0.828 0.172 0.000
M47.99 Spondylosis, unspecified (Site unspecified)
0.827 0.173 0.000
N00-N08 Glomerular diseases
0.825 0.175 0.000
M47.8 Other spondylosis
0.823 0.177 0.000
Y43.4 Immunosuppressive agents
0.822 0.178 0.000
N13.5 Kinking and stricture of ureter without hydronephrosis
0.822 0.178 0.000
N18 Chronic renal failure
0.819 0.181 0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)
0.816 0.184 0.000
N64 Other disorders of breast
0.814 0.186 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.813 0.186 0.000
N18.9 Chronic renal failure, unspecified
0.811 0.189 0.000
E28.2 Polycystic ovarian syndrome
0.811 0.189 0.000
G90 Disorders of autonomic nervous system
0.810 0.190 0.000
M24 Other specific joint derangements
0.808 0.192 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.806 0.193 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.807 0.193 0.000
M25.8 Other specified joint disorders
0.806 0.194 0.000
M35.0 Sicca syndrome [Sjogren]
0.805 0.195 0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)
0.805 0.195 0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction
0.804 0.196 0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
0.801 0.199 0.000
M47.1 Other spondylosis with myelopathy
0.801 0.199 0.000
H18 Other disorders of cornea
0.800 0.200 0.000
M54.3 Sciatica
0.799 0.201 0.000
M87 Osteonecrosis
0.797 0.203 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.795 0.205 0.000
N13.4 Hydroureter
0.794 0.206 0.000
M54.22 Cervicalgia (Cervical region)
0.794 0.206 0.000
Y43.0 Antiallergic and antiemetic drugs
0.793 0.207 0.000
Y91 Evidence of alcohol involvement determined by level of intoxication
0.792 0.208 0.000
G95.2 Cord compression, unspecified
0.792 0.208 0.000
M54.9 Dorsalgia, unspecified
0.791 0.209 0.000
E10.6 With other specified complications
0.790 0.210 0.000
Y40.8 Other systemic antibiotics
0.790 0.210 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.789 0.211 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.786 0.214 0.000
E85 Amyloidosis
0.785 0.215 0.000
E11.2 With renal complications
0.785 0.215 0.000
E86 Volume depletion
0.784 0.216 0.000
W22 Striking against or struck by other objects
0.783 0.217 0.000
E10.0 With coma
0.783 0.217 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.780 0.220 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.778 0.222 0.000
E22 Hyperfunction of pituitary gland
0.775 0.225 0.000
M40-M43 Deforming dorsopathies
0.774 0.226 0.000
M51.4 Schmorl's nodes
0.774 0.226 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.774 0.226 0.000
M80-M85 Disorders of bone density and structure
0.773 0.227 0.000
M53 Other dorsopathies, not elsewhere classified
0.773 0.227 0.000
M34 Systemic sclerosis
0.769 0.231 0.000
E83.3 Disorders of phosphorus metabolism
0.769 0.231 0.000
F60-F69 Disorders of adult personality and behaviour
0.768 0.232 0.000
M49 Spondylopathies in diseases classified elsewhere
0.767 0.233 0.000
F10.1 Harmful use
0.766 0.234 0.000
E24 Cushing's syndrome
0.764 0.236 0.000
Y48 Anaesthetics and therapeutic gases
0.764 0.236 0.000
Y52 Agents primarily affecting the cardiovascular system
0.762 0.238 0.000
E10.4 With neurological complications
0.761 0.239 0.000
M60-M63 Disorders of muscles
0.760 0.240 0.000
M31 Other necrotising vasculopathies
0.759 0.241 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.759 0.241 0.000
M25.86 Other specified joint disorders (Lower leg)
0.759 0.241 0.000
Y43.1 Antineoplastic antimetabolites
0.757 0.243 0.000
M48.09 Spinal stenosis (Site unspecified)
0.757 0.243 0.000
M46 Other inflammatory spondylopathies
0.756 0.244 0.000
F80-F89 Disorders of psychological development
0.754 0.246 0.000
N64.5 Other signs and symptoms in breast
0.753 0.247 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.752 0.248 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.752 0.248 0.000
Y40.3 Macrolides
0.750 0.250 0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.747 0.253 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.746 0.254 0.000
E65-E68 Obesity and other hyperalimentation
0.742 0.258 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.739 0.261 0.000
X10-X19 Contact with heat and hot substances
0.738 0.262 0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
0.738 0.262 0.000
Y00-Y09 Assault
0.737 0.263 0.000
E23 Hypofunction and other disorders of pituitary gland
0.736 0.264 0.000
V20-V29 Motorcycle rider injured in transport accident
0.735 0.265 0.000
G96 Other disorders of central nervous system
0.732 0.268 0.000
E34 Other endocrine disorders
0.731 0.269 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.730 0.270 0.000
M24.2 Disorder of ligament
0.729 0.271 0.000
E00-E07 Disorders of thyroid gland
0.728 0.272 0.000
X50-X57 Overexertion, travel and privation
0.726 0.273 0.000
F30 Manic episode
0.724 0.276 0.000
M25.6 Stiffness of joint, not elsewhere classified
0.724 0.276 0.000
N11 Chronic tubulo-interstitial nephritis
0.722 0.278 0.000
G90.0 Idiopathic peripheral autonomic neuropathy
0.722 0.278 0.000
E29 Testicular dysfunction
0.722 0.278 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.721 0.279 0.000
W50-W64 Exposure to animate mechanical forces
0.720 0.279 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.720 0.280 0.000
E11.1 With ketoacidosis
0.719 0.281 0.000
Y40.9 Systemic antibiotic, unspecified
0.719 0.281 0.000
M47.82 Other spondylosis (Cervical region)
0.718 0.282 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
Y35-Y36 Legal intervention and operations of war
0.717 0.283 0.000
Y10-Y34 Event of undetermined intent
0.717 0.283 0.000
X85-X99 Assault
0.717 0.283 0.000
X30-X39 Exposure to forces of nature
0.717 0.283 0.000
X00-X09 Exposure to smoke, fire and flames
0.717 0.283 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.717 0.283 0.000
W75-W84 Other accidental threats to breathing
0.717 0.283 0.000
W65-W74 Accidental drowning and submersion
0.717 0.283 0.000
V98-V99 Other and unspecified transport accidents
0.717 0.283 0.000
V95-V97 Air and space transport accidents
0.717 0.283 0.000
V90-V94 Water transport accidents
0.717 0.283 0.000
V70-V79 Bus occupant injured in transport accident
0.717 0.283 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.717 0.283 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.717 0.283 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.717 0.283 0.000
V01-V09 Pedestrian injured in transport accident
0.717 0.283 0.000
M51.3 Other specified intervertebral disk degeneration
0.716 0.283 0.000
M51.1 Lumbar and other intervertebral disk disorders with radiculopathy
0.716 0.283 0.000
N25-N29 Other disorders of kidney and ureter
0.716 0.284 0.000
M47.87 Other spondylosis (Lumbosacral region)
0.716 0.284 0.000
E61 Deficiency of other nutrient elements
0.716 0.284 0.000
E21.0 Primary hyperparathyroidism
0.715 0.285 0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.714 0.286 0.000
Y59 Other and unspecified vaccines and biological substances
0.713 0.287 0.000
Y58 Bacterial vaccines
0.713 0.287 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.713 0.287 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.713 0.287 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.713 0.287 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.713 0.287 0.000
H10-H13 Disorders of conjunctiva
0.713 0.287 0.000
H46-H48 Disorders of optic nerve and visual pathways
0.712 0.288 0.000
W22.9 Unspecified place
0.712 0.288 0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue
0.709 0.291 0.000
M54.4 Lumbago with sciatica
0.709 0.291 0.000
F22 Persistent delusional disorders
0.709 0.291 0.000
N64.8 Other specified disorders of breast
0.709 0.291 0.000
E84 Cystic fibrosis
0.708 0.292 0.000
E79 Disorders of purine and pyrimidine metabolism
0.708 0.292 0.000
E77 Disorders of glycoprotein metabolism
0.708 0.292 0.000
E76 Disorders of glycosaminoglycan metabolism
0.708 0.292 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.708 0.292 0.000
E72 Other disorders of amino-acid metabolism
0.708 0.292 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.708 0.292 0.000
E70 Disorders of aromatic amino-acid metabolism
0.708 0.292 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.708 0.292 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.708 0.292 0.000
Y43.9 Primarily systemic agent, unspecified
0.707 0.293 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.707 0.293 0.000
Y43.6 Enzymes, not elsewhere classified
0.707 0.293 0.000
Y43.5 Acidifying and alkalising agents
0.707 0.293 0.000
Y43.2 Antineoplastic natural products
0.707 0.293 0.000
M21.0 Valgus deformity, not elsewhere classified
0.707 0.293 0.000
H55-H59 Other disorders of eye and adnexa
0.707 0.293 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.707 0.293 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.706 0.294 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.705 0.295 0.000
E83.8 Other disorders of mineral metabolism
0.705 0.295 0.000
E83.2 Disorders of zinc metabolism
0.705 0.295 0.000
E83.0 Disorders of copper metabolism
0.705 0.295 0.000
E13 Other specified diabetes mellitus
0.704 0.296 0.000
E12 Malnutrition-related diabetes mellitus
0.704 0.296 0.000
M36 Systemic disorders of connective tissue in diseases classified elsewhere
0.704 0.296 0.000
M33 Dermatopolymyositis
0.704 0.296 0.000
M32 Systemic lupus erythematosus
0.704 0.296 0.000
M30 Polyarteritis nodosa and related conditions
0.704 0.296 0.000
E74 Other disorders of carbohydrate metabolism
0.702 0.298 0.000
E40-E46 Malnutrition
0.701 0.299 0.000
H16 Keratitis
0.700 0.299 0.000
M48.00 Spinal stenosis (Multiple sites in spine)
0.700 0.300 0.000
N99-N99 Other disorders of the genitourinary system
0.700 0.300 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.700 0.300 0.000
F70-F79 Mental retardation
0.700 0.300 0.000
H18.8 Other specified disorders of cornea
0.699 0.300 0.000
H17 Corneal scars and opacities
0.699 0.301 0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
0.698 0.302 0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.698 0.302 0.000
Y98 Lifestyle-related condition
0.698 0.302 0.000
Y97 Environmental-pollution-related condition
0.698 0.302 0.000
Y96 Work-related condition
0.698 0.302 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.697 0.303 0.000
H18.5 Hereditary corneal dystrophies
0.697 0.303 0.000
V40-V49 Car occupant injured in transport accident
0.697 0.303 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.697 0.303 0.000
E10.5 With peripheral circulatory complications
0.696 0.304 0.000
M21.3 Wrist or foot drop (acquired)
0.695 0.304 0.000
M47.0 Anterior spinal and vertebral artery compression syndromes
0.694 0.306 0.000
M48.9 Spondylopathy, unspecified
0.693 0.306 0.000
M48.8 Other specified spondylopathies
0.693 0.306 0.000
M48.4 Fatigue fracture of vertebra
0.693 0.306 0.000
M48.3 Traumatic spondylopathy
0.693 0.306 0.000
M48.2 Kissing spine
0.693 0.306 0.000
M48.1 Ankylosing hyperostosis [Forestier]
0.693 0.306 0.000
N04 Nephrotic syndrome
0.693 0.307 0.000
E26 Hyperaldosteronism
0.693 0.307 0.000
N62 Hypertrophy of breast
0.692 0.308 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.692 0.308 0.000
E32 Diseases of thymus
0.692 0.308 0.000
E31 Polyglandular dysfunction
0.692 0.308 0.000
E30 Disorders of puberty, not elsewhere classified
0.692 0.308 0.000
E25 Adrenogenital disorders
0.692 0.308 0.000
E20 Hypoparathyroidism
0.692 0.308 0.000
X20-X29 Contact with venomous animals and plants
0.692 0.308 0.000
N18.5 Chronic kidney disease, stage 5
0.692 0.308 0.000
E10.8 With unspecified complications
0.691 0.309 0.000
E10.7 With multiple complications
0.691 0.309 0.000
N64.1 Fat necrosis of breast
0.690 0.310 0.000
W21 Striking against or struck by sports equipment
0.690 0.310 0.000
M48.02 Spinal stenosis (Cervical region)
0.689 0.311 0.000
V80-V89 Other land transport accidents
0.689 0.311 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.687 0.313 0.000
M45 Ankylosing spondylitis
0.687 0.313 0.000
M54.30 Sciatica (Multiple sites in spine)
0.687 0.313 0.000
E10.1 With ketoacidosis
0.686 0.314 0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit
0.685 0.315 0.000
M91-M94 Chondropathies
0.685 0.315 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.685 0.315 0.000
M54.99 Dorsalgia, unspecified (Site unspecified)
0.684 0.316 0.000
Y49.2 Other and unspecified antidepressants
0.683 0.317 0.000
N10 Acute tubulo-interstitial nephritis
0.683 0.317 0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.683 0.317 0.000
M48.05 Spinal stenosis (Thoracolumbar region)
0.683 0.317 0.000
M48.04 Spinal stenosis (Thoracic region)
0.683 0.317 0.000
M48.03 Spinal stenosis (Cervicothoracic region)
0.683 0.317 0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.683 0.317 0.000
M87.9 Osteonecrosis, unspecified
0.682 0.318 0.000
F17.1 Harmful use
0.682 0.318 0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)
0.681 0.319 0.000
M47.12 Other spondylosis with myelopathy (Cervical region)
0.680 0.320 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.678 0.322 0.000
M21.6 Other acquired deformities of ankle and foot
0.678 0.322 0.000
W20 Struck by thrown, projected or falling object
0.677 0.323 0.000
E80.4 Gilbert's syndrome
0.677 0.323 0.000
M35.7 Hypermobility syndrome
0.676 0.324 0.000
X84 Intentional self-harm by unspecified means
0.674 0.326 0.000
X83 Intentional self-harm by other specified means
0.674 0.326 0.000
X82 Intentional self-harm by crashing of motor vehicle
0.674 0.326 0.000
X81 Intentional self-harm by jumping or lying before moving object
0.674 0.326 0.000
X80 Intentional self-harm by jumping from a high place
0.674 0.326 0.000
X79 Intentional self-harm by blunt object
0.674 0.326 0.000
X77 Intentional self-harm by steam, hot vapours and hot objects
0.674 0.326 0.000
X76 Intentional self-harm by smoke, fire and flames
0.674 0.326 0.000
X75 Intentional self-harm by explosive material
0.674 0.326 0.000
X74 Intentional self-harm by other and unspecified firearm discharge
0.674 0.326 0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge
0.674 0.326 0.000
X72 Intentional self-harm by handgun discharge
0.674 0.326 0.000
X71 Intentional self-harm by drowning and submersion
0.674 0.326 0.000
X70 Intentional self-harm by hanging, strangulation and suffocation
0.674 0.326 0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.674 0.326 0.000
X68 Intentional self-poisoning by and exposure to pesticides
0.674 0.326 0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours
0.674 0.326 0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
0.674 0.326 0.000
X65 Intentional self-poisoning by and exposure to alcohol
0.674 0.326 0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.674 0.326 0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.674 0.326 0.000
M54.1 Radiculopathy
0.673 0.327 0.000
G95.8 Other specified diseases of spinal cord
0.673 0.327 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.673 0.327 0.000
M87.2 Osteonecrosis due to previous trauma
0.672 0.328 0.000
M54.8 Other dorsalgia
0.671 0.329 0.000
M54.0 Panniculitis affecting regions of neck and back
0.671 0.329 0.000
M00-M03 Infectious arthropathies
0.671 0.329 0.000
M23.0 Cystic meniscus
0.670 0.329 0.000
M25.9 Joint disorder, unspecified
0.670 0.330 0.000
Y44 Agents primarily affecting blood constituents
0.670 0.330 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.670 0.330 0.000
G91 Hydrocephalus
0.670 0.330 0.000
E73 Lactose intolerance
0.670 0.330 0.000
Y57 Other and unspecified drugs and medicaments
0.669 0.331 0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)
0.667 0.333 0.000
G90.9 Disorder of autonomic nervous system, unspecified
0.666 0.334 0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)
0.666 0.334 0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)
0.666 0.334 0.000
M47.94 Spondylosis, unspecified (Thoracic region)
0.666 0.334 0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)
0.666 0.334 0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)
0.666 0.334 0.000
E55 Vitamin D deficiency
0.665 0.335 0.000
N05 Unspecified nephritic syndrome
0.665 0.335 0.000
F31 Bipolar affective disorder
0.665 0.335 0.000
N02 Recurrent and persistent haematuria
0.665 0.335 0.000
Y91.9 Alcohol involvement, not otherwise specified
0.663 0.337 0.000
M88 Paget's disease of bone [osteitis deformans]
0.662 0.337 0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere
0.662 0.338 0.000
N15 Other renal tubulo-interstitial diseases
0.662 0.338 0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
0.662 0.338 0.000
M25.4 Effusion of joint
0.660 0.340 0.000
V10-V19 Pedal cyclist injured in transport accident
0.660 0.340 0.000
F38 Other mood [affective] disorders
0.659 0.341 0.000
F34 Persistent mood [affective] disorders
0.659 0.341 0.000
F39 Unspecified mood [affective] disorder
0.659 0.341 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.659 0.341 0.000
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.659 0.341 0.000
G99.2 Myelopathy in diseases classified elsewhere
0.659 0.341 0.000
G20-G26 Extrapyramidal and movement disorders
0.658 0.342 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.658 0.342 0.000
N13.7 Vesicoureteral-reflux-associated uropathy
0.655 0.345 0.000
E04 Other non-toxic goitre
0.654 0.346 0.000
G70-G73 Diseases of myoneural junction and muscle
0.653 0.347 0.000
N13.9 Obstructive and reflux uropathy, unspecified
0.652 0.348 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.652 0.348 0.000
F22.0 Delusional disorder
0.652 0.348 0.000
Chapter VIII Diseases of the ear and mastoid process
0.652 0.348 0.000
M51.9 Intervertebral disk disorder, unspecified
0.650 0.350 0.000
H04 Disorders of lachrymal system
0.650 0.350 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.649 0.351 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.649 0.351 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.649 0.351 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.649 0.351 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.649 0.351 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.649 0.351 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.649 0.351 0.000
M23.80 Other internal derangements of knee (Multiple sites)
0.649 0.351 0.000
M54.6 Pain in thoracic spine
0.648 0.352 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.648 0.352 0.000
Y40.7 Antifungal antibiotics, systemically used
0.648 0.352 0.000
Y40.6 Rifamycins
0.648 0.352 0.000
Y40.5 Aminoglycosides
0.648 0.352 0.000
Y40.4 Tetracyclines
0.648 0.352 0.000
Y40.2 Chloramphenicol group
0.648 0.352 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.648 0.352 0.000
E11.0 With coma
0.647 0.353 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.646 0.354 0.000
F99-F99 Unspecified mental disorder
0.645 0.354 0.000
M23.9 Internal derangement of knee, unspecified
0.644 0.356 0.000
E87.6 Hypokalaemia
0.644 0.356 0.000
M47.89 Other spondylosis (Site unspecified)
0.643 0.357 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.643 0.357 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.643 0.357 0.000
F11 Mental and behavioural disorders due to use of opioids
0.643 0.357 0.000
M23.1 Discoid meniscus (congenital)
0.641 0.358 0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)
0.641 0.359 0.000
X62.0 Home
0.640 0.360 0.000
X62.8 Other specified place
0.640 0.360 0.000
X62.7 Farm
0.640 0.360 0.000
X62.6 Industrial and construction area
0.640 0.360 0.000
X62.5 Trade and service area
0.640 0.360 0.000
X62.4 Street and highway
0.640 0.360 0.000
X62.3 Sports and athletics area
0.640 0.360 0.000
X62.2 School, other institution and public administrative area
0.640 0.360 0.000
X62.1 Residential institution
0.640 0.360 0.000
M81 Osteoporosis without pathological fracture
0.640 0.360 0.000
E22.1 Hyperprolactinaemia
0.639 0.360 0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)
0.639 0.361 0.000
M35.1 Other overlap syndromes
0.639 0.361 0.000
M90 Osteopathies in diseases classified elsewhere
0.639 0.361 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.636 0.364 0.000
G98 Other disorders of nervous system, not elsewhere classified
0.636 0.364 0.000
G92 Toxic encephalopathy
0.636 0.364 0.000
M86 Osteomyelitis
0.634 0.365 0.000
E11.8 With unspecified complications
0.634 0.366 0.000
E11.7 With multiple complications
0.634 0.366 0.000
N18.4 Chronic kidney disease, stage 4
0.633 0.367 0.000
W46 Contact with hypodermic needle
0.633 0.367 0.000
W45 Foreign body or object entering through skin
0.633 0.367 0.000
W43 Exposure to vibration
0.633 0.367 0.000
W42 Exposure to noise
0.633 0.367 0.000
W41 Exposure to high-pressure jet
0.633 0.367 0.000
W40 Explosion of other materials
0.633 0.367 0.000
W39 Discharge of firework
0.633 0.367 0.000
W38 Explosion and rupture of other specified pressurised devices
0.633 0.367 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.633 0.367 0.000
W36 Explosion and rupture of gas cylinder
0.633 0.367 0.000
W35 Explosion and rupture of boiler
0.633 0.367 0.000
W34 Discharge from other and unspecified firearms
0.633 0.367 0.000
W33 Rifle, shotgun and larger firearm discharge
0.633 0.367 0.000
W32 Handgun discharge
0.633 0.367 0.000
W31 Contact with other and unspecified machinery
0.633 0.367 0.000
W30 Contact with agricultural machinery
0.633 0.367 0.000
W28 Contact with powered lawn mower
0.633 0.367 0.000
W27 Contact with nonpowered hand tool
0.633 0.367 0.000
W26 Contact with knife, sword or dagger
0.633 0.367 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.633 0.367 0.000
E10.2 With renal complications
0.632 0.368 0.000
M35.9 Systemic involvement of connective tissue, unspecified
0.630 0.370 0.000
M35.8 Other specified systemic involvement of connective tissue
0.630 0.370 0.000
M35.6 Relapsing panniculitis [Weber-Christian]
0.630 0.370 0.000
M35.5 Multifocal fibrosclerosis
0.630 0.370 0.000
M35.4 Diffuse (eosinophilic) fasciitis
0.630 0.370 0.000
M35.2 Behcet's disease
0.630 0.370 0.000
X78 Intentional self-harm by sharp object
0.630 0.370 0.000
M24.8 Other specific joint derangements, not elsewhere classified
0.629 0.370 0.000
M54.37 Sciatica (Lumbosacral region)
0.629 0.371 0.000
H11 Other disorders of conjunctiva
0.628 0.372 0.000
M89 Other disorders of bone
0.628 0.372 0.000
M25.3 Other instability of joint
0.628 0.372 0.000
F32.8 Other depressive episodes
0.628 0.372 0.000
E28.9 Ovarian dysfunction, unspecified
0.627 0.372 0.000
E28.8 Other ovarian dysfunction
0.627 0.372 0.000
E28.3 Primary ovarian failure
0.627 0.372 0.000
E28.1 Androgen excess
0.627 0.372 0.000
E28.0 Oestrogen excess
0.627 0.372 0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)
0.627 0.373 0.000
Y54.3 Benzothiadiazine derivatives
0.626 0.373 0.000
G95.1 Vascular myelopathies
0.626 0.374 0.000
N64.4 Mastodynia
0.625 0.374 0.000
H47 Other disorders of optic [2nd] nerve and visual pathways
0.624 0.376 0.000
F32.0 Mild depressive episode
0.623 0.377 0.000
M25.81 Other specified joint disorders (Shoulder region)
0.623 0.377 0.000
M34.1 CR(E)ST syndrome
0.623 0.377 0.000
F50 Eating disorders
0.622 0.378 0.000
G03 Meningitis due to other and unspecified causes
0.622 0.378 0.000
M31.3 Wegener's granulomatosis
0.621 0.379 0.000
E24.9 Cushing's syndrome, unspecified
0.620 0.380 0.000
E61.1 Iron deficiency
0.620 0.380 0.000
M21.2 Flexion deformity
0.619 0.380 0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)
0.619 0.381 0.000
M24.6 Ankylosis of joint
0.618 0.382 0.000
E04.1 Non-toxic single thyroid nodule
0.618 0.382 0.000
F60 Specific personality disorders
0.618 0.382 0.000
G04 Encephalitis, myelitis and encephalomyelitis
0.618 0.382 0.000
H21 Other disorders of iris and ciliary body
0.617 0.383 0.000
M22 Disorders of patella
0.615 0.385 0.000
T40.2 Other opioids
0.615 0.385 0.000
E27 Other disorders of adrenal gland
0.614 0.386 0.000
H18.4 Corneal degeneration
0.614 0.386 0.000
M84 Disorders of continuity of bone
0.614 0.386 0.000
E85.9 Amyloidosis, unspecified
0.613 0.387 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.612 0.388 0.000
M24.21 Disorder of ligament (Shoulder region)
0.612 0.388 0.000
H55 Nystagmus and other irregular eye movements
0.612 0.388 0.000
M53.3 Sacrococcygeal disorders, not elsewhere classified
0.611 0.389 0.000
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot
0.611 0.389 0.000
M25.84 Other specified joint disorders (Hand)
0.610 0.390 0.000
N13.8 Other obstructive and reflux uropathy
0.609 0.391 0.000
E23.2 Diabetes insipidus
0.609 0.391 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.609 0.391 0.000
E63 Other nutritional deficiencies
0.609 0.391 0.000
E56 Other vitamin deficiencies
0.609 0.391 0.000
E51 Thiamine deficiency
0.609 0.391 0.000
E50 Vitamin A deficiency
0.609 0.391 0.000
E60 Dietary zinc deficiency
0.609 0.391 0.000
E59 Dietary selenium deficiency
0.609 0.391 0.000
E58 Dietary calcium deficiency
0.609 0.391 0.000
E54 Ascorbic acid deficiency
0.609 0.391 0.000
E52 Niacin deficiency [pellagra]
0.609 0.391 0.000
W44 Foreign body entering into or through eye or natural orifice
0.608 0.391 0.000
M21.9 Acquired deformity of limb, unspecified
0.608 0.392 0.000
M21.8 Other specified acquired deformities of limbs
0.608 0.392 0.000
M21.7 Unequal limb length (acquired)
0.608 0.392 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.